Heat Biologics Delivers Poster Presentation at the AACR Annual Meeting 2019
Animal Study Demonstrates Combination of HS-110 and HS-130 Yields Three-Fold Increase in Anti-Tumor CD8+ T-cell Expansion DURHAM, NC / ACCESSWIRE...
user
Savara to Present at the H.C. Wainwright Global Life Sciences Conference in London
AUSTIN, TX / ACCESSWIRE / April 2, 2019 / Savara Inc. (NASDAQ: SVRA), an orphan lung disease company, today announced...
NanoVibronix Provides Year-End Business Update
Reports on Commercial Progress for both PainShield® and UroShield® ELMSFORD, NY / ACCESSWIRE / April 2, 2019 / NanoVibronix, Inc.,...
Dthera Sciences Announces Pursuit of Strategic Transaction
SAN DIEGO, CA / ACCESSWIRE / April 2, 2019 / Dthera™ Sciences (OTCQB: DTHR) a leading digital therapeutic company specializing...
Milestone Scientific Reports 70% Year-Over-Year Revenue Growth and Positive Net Income for the Fourth Quarter of 2018
LIVINGSTON, NJ / ACCESSWIRE / April 2, 2019 / Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized...
Patient Six Cancer-Free Twelve Months After Single Anti-Cancer Treatment
Results of Phase Ib Non-Muscle Invasive Bladder Cancer ("NMIBC") Clinical Study Demonstrate a 66% Complete Response ("CR") at the Therapeutic...
Genmed appoints Nicky Carless as national sales manager
April 2, 2019 – Genmed, a specialist provider of vendor neutral managed services to the NHS, today announces the appointment...
Gateshead Health extends use of BridgeHead’s HealthStore®
BridgeHead’s Independent Clinical Archive will now house all medical images across the TrustASHTEAD, UK – 2 April 2019 – As...
Jaguar Health Subsidiary Napo Pharmaceuticals Issues Further Regulatory Update Regarding Potential Follow-on Indication for Mytesi
SAN FRANSISCO, CA / ACCESSWIRE / April 2, 2019 / Napo Pharmaceuticals, Inc. (Napo), a human health company developing and...
Dr. Sarah Fakih joins MorphoSys as Head of Corporate Communications and Investor Relations
PLANEGG/MUNICH GERMANY / ACCESSWIRE / April 1, 2019 / Dr. Sarah Fakih joined MorphoSys AG (FSE: MOR; Prime Standard Segment,...
ReShape Lifesciences Announces Fourth Quarter and Full Year 2018 Financial Results
SAN CLEMENTE, CA / ACCESSWIRE / April 1, 2019 / ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive...
Kadmon Announces Appointment of Arthur Kirsch to Board of Directors
NEW YORK, NY / ACCESSWIRE / April 1, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Arthur Kirsch...
NHS doctors train using virtual reality to improve care for people with diabetes
The NHS England diabetes team has partnered with Oxford Medical Simulation to train doctors using virtual reality. Doctors can now...
Positive Pilot Phase 3 Data Position VistaGen’s PH94B Neuroactive Nasal Spray for Pivotal Phase 3 Development as a Novel, As-Needed Treatment for Social Anxiety Disorder
PH94B has potential to be the First FDA-Approved PRN Treatment for Social Anxiety Disorder New Findings Presented at the 2019...
Experion Completes First Shipment to the Province of Saskatchewan
CALGARY, AB / ACCESSWIRE / April 1, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (OTC...
ReShape Lifesciences Implants First Patient in ENDURE II Trial to Support CE Marking of ReShape Vest
SAN CLEMENTE, CA / ACCESSWIRE / April 1, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive...
Savara Initiates Phase 2a Clinical Study of Molgradex for the Treatment of NTM Lung Infection in People Living with Cystic Fibrosis
AUSTIN, TX / ACCESSWIRE / April 1, 2019 / Savara Inc. (NASDAQ: SVRA), an orphan lung disease company, today announced...
Parallax Health Sciences Reports 2018 Operating and Financial Results Records Net Income of $16.3 Million
Initiates $6 Million Equity Financing Company Now Positioned for Growth through Execution on Multi-faceted Strategy SANTA MONICA, CALIF / ACCESSWIRE...
EVOTEC AG COMPLETES CONVERSION INTO EVOTEC SE
HAMBURG, GERMANY / ACCESSWIRE / April 1, 2019 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today...
Completion of Name Change and Consolidation
VANCOUVER, BC / ACCESSWIRE / March 28, 2019 / Canland Health Corp. (formerly, 1155176 B.C. LTD.) (the "Company") is pleased...